A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia

NCT03742518 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

675

Enrollment

INDUSTRY

Sponsor class

Conditions

Androgenetic Alopecia

Interventions

DRUG: Topical SM04554 solution
DRUG: Topical SM04554 solution
DRUG: Topical vehicle solution

Sponsor

Biosplice Therapeutics, Inc.